cycloheptanone: structure
ID Source | ID |
---|---|
PubMed CID | 10400 |
CHEMBL ID | 18607 |
SCHEMBL ID | 6077 |
MeSH ID | M0040462 |
Synonym |
---|
qh80295937 , |
unii-qh80295937 |
LS-13306 |
ai3-09538 |
hsdb 2819 |
nsc 9471 |
einecs 207-937-6 |
suberone |
502-42-1 |
ketoheptamethylene |
nsc-9471 |
nsc9471 |
wln: l7vtj |
suberon |
cycloheptanone |
ketocycloheptane |
inchi=1/c7h12o/c8-7-5-3-1-2-4-6-7/h1-6h |
cycloheptanone, 99% |
AKOS000118914 |
CHEMBL18607 , |
cycloheptanon |
bdbm50028831 |
FT-0624172 |
cycloheptanone [mi] |
SCHEMBL6077 |
cyclo-heptanone |
DTXSID8060113 |
mfcd00004159 |
J-520144 |
F0001-1310 |
cycloheptanone, 98+% |
Q413525 |
STL199038 |
AMY3995 |
D89253 |
EN300-19194 |
Z104473100 |
Protein | Taxonomy | Measurement | Average | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | IC50 (µMol) | 510.0000 | 0.9600 | 5.3200 | 8.0000 | AID155162 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Process | via Protein(s) | Taxonomy |
---|---|---|
methylation | Phenylethanolamine N-methyltransferase | Bos taurus (cattle) |
epinephrine biosynthetic process | Phenylethanolamine N-methyltransferase | Bos taurus (cattle) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Process | via Protein(s) | Taxonomy |
---|---|---|
phenylethanolamine N-methyltransferase activity | Phenylethanolamine N-methyltransferase | Bos taurus (cattle) |
[Information is prepared from geneontology information from the June-17-2024 release] |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID155162 | Inhibitory activity against phenylethanolamine N-methyl-transferase | 1981 | Journal of medicinal chemistry, Jan, Volume: 24, Issue:1 | Importance of the aromatic ring in adrenergic amines. 5. Nonaromatic analogues of phenylethanolamine as inhibitors of phenylethanolamine N-methyltransferase: role of hydrophobic and steric interactions. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (6.25) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 7 (43.75) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (6.25%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 15 (93.75%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |